Industry News
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual Faces of Glaucoma Campaign

Bausch + Lomb and the Glaucoma Research Foundation (GRF) have partnered for the second annual Faces ...

read more
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual Faces of Glaucoma Campaign
January 08, 2025
Canyon Labs Acquires iuvo BioScience’s Lab Services and Consulting Divisions

Canyon Labs, a leader in analytical and packaging lab testing and consulting for medical devices and...

read more
Canyon Labs Acquires iuvo BioScience’s Lab Services and Consulting Divisions
January 08, 2025
Lumibird Medical Rebrands Its Japanese Subsidiary

Lumibird Medical has announced the rebranding of its Japanese subsidiary. Previously operating under...

read more
Lumibird Medical Rebrands Its Japanese Subsidiary
January 07, 2025
Oculis Announces Positive Phase 2 Results for OCS-05 in Acute Optic Neuritis

Oculis has reported positive topline results from its Phase 2 ACUITY trial evaluating OCS-05, a nove...

read more
Oculis Announces Positive Phase 2 Results for OCS-05 in Acute Optic Neuritis
January 07, 2025
Cencora Completes Acquisition of Retina Consultants of America

Cencora has officially completed its acquisition of Retina Consultants of America (RCA), a managemen...

read more
Cencora Completes Acquisition of Retina Consultants of America
January 06, 2025
Ocugen Advances Phase 2 of OCU410 ArMaDa Clinical Trial

Ocugen has announced that the second phase of the OCU410 ArMaDa clinical trial will continue followi...

read more
Ocugen Advances Phase 2 of OCU410 ArMaDa Clinical Trial
January 06, 2025
Regeneron Acquires UK-Based Biotech Oxular

Regeneron, a global biotechnology leader, has acquired Oxular, a UK-based clinical-stage company spe...

read more
Regeneron Acquires UK-Based Biotech Oxular
January 06, 2025
Valo Health Suspends Development of OPL-0401 for Diabetic Retinopathy After Phase 2 Study

Valo Health has announced the results of its Phase 2 SPEC¬TRA study evaluating OPL-0401 in patients ...

read more
Valo Health Suspends Development of OPL-0401 for Diabetic Retinopathy After Phase 2 Study
January 03, 2025
Prevent Blindness Offers Free Glaucoma Resources for Patients, Care Partners, and Professionals

In recognition of National Glaucoma Awareness Month in January, the non-profit organization Prevent ...

read more
Prevent Blindness Offers Free Glaucoma Resources for Patients, Care Partners, and Professionals
January 02, 2025
Long-Term Efficacy of MicroPulse TLT Validated for Glaucoma Management

Iridex Corporation, a global leader in laser-based medical systems for glaucoma and retinal disease ...

read more
Long-Term Efficacy of MicroPulse TLT Validated for Glaucoma Management
December 25, 2024
More